首页>AIDS Research and Human Retroviruses>Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir
作者单位:CCMD, CC, National Institutes of Health, Bethesda, MD, United States[1]Institute of Liver and Biliary Sciences, New Delhi, India[2]Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National[3]